The pharmaceutical industry faces significant challenges in launching new drugs, necessitating meticulous planning and execution across various enterprise systems. IT applications have emerged as critical enablers, ensuring pharmaceutical companies are well-prepared for these complex undertakings. This paper delves into the role of IT applications in enhancing readiness for pharmaceutical drug launches, focusing on key areas such as supply chain management, regulatory compliance, marketing strategies, and data integration. Advanced IT solutions streamline operations, improve coordination, and mitigate risks, thereby supporting the intricate processes involved in drug launches. By examining case studies, this paper highlights the practical benefits of IT applications, showcasing their contribution to successful and timely market entries. For instance, robust supply chain management systems help ensure the timely availability of necessary materials, while regulatory compliance tools assist in navigating the stringent regulatory landscape, reducing delays in product approval. Additionally, sophisticated marketing strategies enabled by IT applications enhance market penetration and product visibility, ensuring a competitive edge. Data integration platforms facilitate seamless communication across departments, improving decision-making and operational efficiency. The integration of these advanced IT solutions is essential for managing the complexities of drug launches, ultimately supporting the goal of delivering new therapies to patients efficiently and effectively. Moreover, the paper underscores the importance of a robust IT infrastructure in managing potential risks and uncertainties, such as supply chain disruptions and regulatory hurdles. The insights gained from the case studies provide a comprehensive understanding of how IT applications can be leveraged to achieve successful pharmaceutical product launches. As the pharmaceutical industry continues to evolve, the role of IT solutions will become increasingly pivotal, underscoring the need for continuous innovation and investment in IT capabilities to maintain a competitive advantage and ensure the successful introduction of new drugs to the market.